Back to calendar
Recursion Pharmaceuticals, Inc. (RXRX) Earnings
RXRX reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.24
Actual EPS: $-0.22
EPS surprise: 16.98%
Company overview
Market Cap$1.8B
PriceUSD 3.34
EPS (TTM)-1.20
52-week high7.18
52-week low2.77
SectorHealth Technology
IndustryBiotechnology
Employees600